FIELD: medicine.
SUBSTANCE: various polypeptide of VII human coagulation factor characterized by high coagulating activity in comparison to natural factor VIIa and not requiring tissue factor induction for development. Structurally new factors VII are amino acid sequence of natural protein containing substitute L305 Val/Tyr/Ile and one or more substitutes including K337 Ala/Gly/Val/Ser//Thr/Asn/Gln/Asp/Glu; V158 Ser/Thr/Asn/Gln/Asp/Glu; E296 Arg/Lys/Val and M298 Lys/Arg/Gln/Asn. Genetic make-up and expression systems for production of described various factor VII by means of recombinant DNA technologies, as well as application of new polypeptides composing pharmaceutical formulations.
EFFECT: compounds are used for bleeding treatment and coagulation system upkeeping.
31 cl, 1 dwg, 7 ex
Authors
Dates
2008-05-27—Published
2002-09-26—Filed